Skip to main content
Top
Published in: Diabetologia 7/2004

01-07-2004 | Article

Simple non-invasive assessment of advanced glycation endproduct accumulation

Authors: R. Meerwaldt, R. Graaff, P. H. N. Oomen, T. P. Links, J. J. Jager, N. L. Alderson, S. R. Thorpe, J. W. Baynes, R. O. B. Gans, A. J. Smit

Published in: Diabetologia | Issue 7/2004

Login to get access

Abstract

Aims/hypothesis

The accumulation of AGE is thought to play a role in the pathogenesis of chronic complications of diabetes mellitus and renal failure. All current measurements of AGE accumulation require invasive sampling. We exploited the fact that several AGE exhibit autofluorescence to develop a non-invasive tool for measuring skin AGE accumulation, the Autofluorescence Reader (AFR). We validated its use by comparing the values obtained using the AFR with the AGE content measured in extracts from skin biopsies of diabetic and control subjects.

Methods

Using the AFR with an excitation light source of 300–420 nm, fluorescence of the skin was measured at the arm and lower leg in 46 patients with diabetes (Type 1 and 2) and in 46 age- and sex-matched control subjects, the majority of whom were Caucasian. Autofluorescence was defined as the average fluorescence per nm over the entire emission spectrum (420–600 nm) as ratio of the average fluorescence per nm over the 300–420-nm range. Skin biopsies were obtained from the same site of the arm, and analysed for collagen-linked fluorescence (CLF) and specific AGE: pentosidine, N ε -(carboxymethyl)lysine (CML) and N ε -(carboxyethyl)lysine (CEL).

Results

Autofluorescence correlated with CLF, pentosidine, CML, and CEL (r=0.47–0.62, p≤0.002). In 32 of 46 diabetic patients (70%), autofluorescence values were above the 95% CI of the mean value in control subjects, and correlated with age, diabetes duration, mean HbA1c of the previous year and creatinine levels.

Conclusions/interpretation

The AFR offers a simple alternative to invasive measurement of AGE accumulation and, to date, has been validated in non-pigmented skin. The AFR may prove to be a useful clinical tool for rapid risk assessment of AGE-related long-term complications in diabetes mellitus and in other conditions associated with AGE accumulation.
Literature
1.
go back to reference Schleicher E, Wagner E, Nerlich AG (1997) Increased accumulation of the glycoxidation product N ε -(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99:457–468CrossRefPubMedPubMedCentral Schleicher E, Wagner E, Nerlich AG (1997) Increased accumulation of the glycoxidation product N ε -(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99:457–468CrossRefPubMedPubMedCentral
2.
go back to reference Stitt AW, He C, Friedman S et al. (1997) Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med 3:617–627PubMedPubMedCentral Stitt AW, He C, Friedman S et al. (1997) Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med 3:617–627PubMedPubMedCentral
3.
go back to reference Miyata T, Wada Y, Cai Z et al. (1997) Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 51:1170–1181CrossRefPubMed Miyata T, Wada Y, Cai Z et al. (1997) Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 51:1170–1181CrossRefPubMed
4.
go back to reference Smith MA, Taneda S, Richey PL et al. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710–5714CrossRefPubMedPubMedCentral Smith MA, Taneda S, Richey PL et al. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710–5714CrossRefPubMedPubMedCentral
5.
go back to reference Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR (1986) Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N Eng J Med 314:403–408CrossRef Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR (1986) Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N Eng J Med 314:403–408CrossRef
6.
go back to reference Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications. A new perspective on an old Paradigm. Diabetes 48:1–9CrossRefPubMed Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications. A new perspective on an old Paradigm. Diabetes 48:1–9CrossRefPubMed
7.
go back to reference The DCCT research group (1993) The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes: The Diabetes Control and Complications Trial. N Engl J Med 329:977–986CrossRef The DCCT research group (1993) The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes: The Diabetes Control and Complications Trial. N Engl J Med 329:977–986CrossRef
8.
go back to reference Monnier VM, Bautista O, Kenny D et al. (1999) Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes. Diabetes 48:870–880CrossRefPubMedPubMedCentral Monnier VM, Bautista O, Kenny D et al. (1999) Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes. Diabetes 48:870–880CrossRefPubMedPubMedCentral
9.
go back to reference Monnier VM, Sell DR, Abdul-Karim FW, Emancipator SN (1988) Collagen browning and cross-linking are increased in chronic experimental hyperglycemia. Relevance to diabetes and ageing. Diabetes 37:867–872CrossRefPubMed Monnier VM, Sell DR, Abdul-Karim FW, Emancipator SN (1988) Collagen browning and cross-linking are increased in chronic experimental hyperglycemia. Relevance to diabetes and ageing. Diabetes 37:867–872CrossRefPubMed
10.
go back to reference Nishikawa T, Edelstein D, Du XL et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790CrossRefPubMed Nishikawa T, Edelstein D, Du XL et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790CrossRefPubMed
11.
go back to reference Thornalley PJ (1998) Cell activation by glycated proteins, AGE receptors, receptor recognition factors and functional classification of AGE. Cell Mol Biol 44:1013–1023PubMed Thornalley PJ (1998) Cell activation by glycated proteins, AGE receptors, receptor recognition factors and functional classification of AGE. Cell Mol Biol 44:1013–1023PubMed
12.
go back to reference Beisswenger PJ, Makita Z, Curphey TJ et al. (1995) Formation of immunochemical advanced glycosylation end products precede and correlate with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824–829CrossRefPubMed Beisswenger PJ, Makita Z, Curphey TJ et al. (1995) Formation of immunochemical advanced glycosylation end products precede and correlate with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824–829CrossRefPubMed
13.
go back to reference Makita Z, Radoff S, Rayfield EJ et al. (1991) Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836–842CrossRefPubMed Makita Z, Radoff S, Rayfield EJ et al. (1991) Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836–842CrossRefPubMed
14.
go back to reference Hammes HP, Brownlee M, Lin J, Schleicher E, Bretzel RG (1999) Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product N-epsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia 42:603–607CrossRefPubMed Hammes HP, Brownlee M, Lin J, Schleicher E, Bretzel RG (1999) Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product N-epsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia 42:603–607CrossRefPubMed
15.
go back to reference Kiuchi K, Nejima J, Takano T, Ohta M, Hashimoto H (2001) Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart 85:87–91CrossRefPubMedPubMedCentral Kiuchi K, Nejima J, Takano T, Ohta M, Hashimoto H (2001) Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart 85:87–91CrossRefPubMedPubMedCentral
16.
17.
go back to reference Wolffenbuttel BH, Boulanger CM, Crijns FR et al. (1998) Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95:4630–4634CrossRefPubMedPubMedCentral Wolffenbuttel BH, Boulanger CM, Crijns FR et al. (1998) Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95:4630–4634CrossRefPubMedPubMedCentral
18.
go back to reference Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G (1991) Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rats. Diabetes 40:1328–1335CrossRefPubMed Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G (1991) Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rats. Diabetes 40:1328–1335CrossRefPubMed
19.
go back to reference Hricik DE, Wu YC, Schulak A, Friedlander MA (1996) Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin Transplantation 10:568–573 Hricik DE, Wu YC, Schulak A, Friedlander MA (1996) Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin Transplantation 10:568–573
20.
go back to reference Dorrian CA, Cathcart S, Clausen J, Shapiro D, Dominiczak MH (1998) Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell Mol Biol 44:1069–1079PubMed Dorrian CA, Cathcart S, Clausen J, Shapiro D, Dominiczak MH (1998) Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell Mol Biol 44:1069–1079PubMed
21.
go back to reference Jager J, Oomen PHN, Sluiter WJ, Reitsma WD, Smit AJ (1997) Improved reproducibility of the “Large-Window” method of assessing transcapillary and interstitial fluorescein diffusion in the skin in healthy subjects and in subjects with insulin-dependent diabetes mellitus. Int J Microcirc Clin Exp 17:150–158CrossRefPubMed Jager J, Oomen PHN, Sluiter WJ, Reitsma WD, Smit AJ (1997) Improved reproducibility of the “Large-Window” method of assessing transcapillary and interstitial fluorescein diffusion in the skin in healthy subjects and in subjects with insulin-dependent diabetes mellitus. Int J Microcirc Clin Exp 17:150–158CrossRefPubMed
22.
go back to reference Sato E, Mori F, Igarashi S et al. (2001) Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy. Diabetes Care 24:479–482CrossRefPubMed Sato E, Mori F, Igarashi S et al. (2001) Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy. Diabetes Care 24:479–482CrossRefPubMed
23.
go back to reference Abiko T, Abiko A, Ishiko S et al. (1999) Relationship between autofluorescence and advanced glycation end products in diabetic lenses. Exp Eye Res 68:361–366CrossRefPubMed Abiko T, Abiko A, Ishiko S et al. (1999) Relationship between autofluorescence and advanced glycation end products in diabetic lenses. Exp Eye Res 68:361–366CrossRefPubMed
24.
go back to reference Ishino Y, Yokoi N, Yashara T et al. (2001) Investigation of corneal autofluorescence in diabetic patients. Jpn J Opthalmol 45:116CrossRef Ishino Y, Yokoi N, Yashara T et al. (2001) Investigation of corneal autofluorescence in diabetic patients. Jpn J Opthalmol 45:116CrossRef
25.
go back to reference Van Schaik HJ, Alkemade C, Swart W, van Best JA (1999) Autofluorescence of the diabetic and healthy human cornea in vivo at different excitation wavelengths. Exp Eye Res 68:1–8CrossRef Van Schaik HJ, Alkemade C, Swart W, van Best JA (1999) Autofluorescence of the diabetic and healthy human cornea in vivo at different excitation wavelengths. Exp Eye Res 68:1–8CrossRef
26.
go back to reference Coremans JMC, Ince C, Bruining HA, Puppels GJ (1997) (Semi-) quantitative analysis of reduced nicotinamide adenine dinucleotide fluorescence images of blood perfused rat heart. Biophys J 72:1849–1860CrossRefPubMedPubMedCentral Coremans JMC, Ince C, Bruining HA, Puppels GJ (1997) (Semi-) quantitative analysis of reduced nicotinamide adenine dinucleotide fluorescence images of blood perfused rat heart. Biophys J 72:1849–1860CrossRefPubMedPubMedCentral
27.
go back to reference Na R, Stender IM, Henriksen M, Wulf HC (2001) Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J Invest Dermatol 116:536–540CrossRefPubMed Na R, Stender IM, Henriksen M, Wulf HC (2001) Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J Invest Dermatol 116:536–540CrossRefPubMed
28.
go back to reference Dyer DG, Dunn JA, Thorpe SR et al. (1993) Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463–2469CrossRefPubMedPubMedCentral Dyer DG, Dunn JA, Thorpe SR et al. (1993) Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463–2469CrossRefPubMedPubMedCentral
29.
go back to reference Ahmed MU, Brinkmann-Frye E, Degenhardt TP, Thorpe SR, Baynes JW (1997) N ε -(carboxymethyl)lysine, a product of chemical modification of protein by methylglyoxal, increases with age in human lens proteins. Biochem J 324:565–570CrossRefPubMedPubMedCentral Ahmed MU, Brinkmann-Frye E, Degenhardt TP, Thorpe SR, Baynes JW (1997) N ε -(carboxymethyl)lysine, a product of chemical modification of protein by methylglyoxal, increases with age in human lens proteins. Biochem J 324:565–570CrossRefPubMedPubMedCentral
30.
go back to reference Maekawa T, Rathinasamy TK, Altman KI, Forbes WF (1970) Changes in collagen with age. 1. The extraction of acid soluble collagen from the skin of mice. Exp Gerontol 5:177–186CrossRefPubMed Maekawa T, Rathinasamy TK, Altman KI, Forbes WF (1970) Changes in collagen with age. 1. The extraction of acid soluble collagen from the skin of mice. Exp Gerontol 5:177–186CrossRefPubMed
31.
go back to reference Wolffenbuttel BHR, Giordano D, Founds HW, Bucala R (1996) Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet 347:513–515CrossRefPubMed Wolffenbuttel BHR, Giordano D, Founds HW, Bucala R (1996) Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet 347:513–515CrossRefPubMed
32.
go back to reference Nicoll ID, Stitt AW, Moore JE (1998) Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 4:594–601 Nicoll ID, Stitt AW, Moore JE (1998) Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 4:594–601
33.
go back to reference McCance DR, Dyer DG, Dunn JA et al. (1993) Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470–2478CrossRefPubMedPubMedCentral McCance DR, Dyer DG, Dunn JA et al. (1993) Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470–2478CrossRefPubMedPubMedCentral
34.
go back to reference Koschinsky T, He CJ, Mitsuhashi T et al. (1997) Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 94:6474–6479CrossRefPubMedPubMedCentral Koschinsky T, He CJ, Mitsuhashi T et al. (1997) Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 94:6474–6479CrossRefPubMedPubMedCentral
Metadata
Title
Simple non-invasive assessment of advanced glycation endproduct accumulation
Authors
R. Meerwaldt
R. Graaff
P. H. N. Oomen
T. P. Links
J. J. Jager
N. L. Alderson
S. R. Thorpe
J. W. Baynes
R. O. B. Gans
A. J. Smit
Publication date
01-07-2004
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1451-2

Other articles of this Issue 7/2004

Diabetologia 7/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.